Skip to main content
. 2023 Jun 5;18:37. doi: 10.1186/s13024-023-00627-2

Fig. 3.

Fig. 3

Roadmap: Acute inflammatory events and Alzheimer’s disease To overcome prior barriers to progress in the immunity-AD field, longitudinal, multimodal appraisal of acute inflammatory events in diverse cohorts is needed. A proposed roadmap of studies needed to address gaps in the literature is depicted, focusing on biological, neuroimaging, and environmental assessments of the relationship between acute inflammatory exposures and long-term outcomes, as well as the development of interventional trials aimed at resolving systemic inflammation